Diarrheal Disease

Etiology and Risk Factors

Recent antibiotics, hospitalization, travel, contaminated food or water, and outbreaks substantially alter the initial differential (Mills & Ciorba, 2019; Shane et al., 2017).

Epidemiology and Clinical Context

Population context: Children and frail older adults may develop clinically important dehydration quickly; an immunocompromised host is at risk for more severe, persistent, or opportunistic infection. Recent antibiotics, hospitalization, travel, contaminated food or water, and outbreaks substantially alter the initial differential (Mills & Ciorba, 2019; Shane et al., 2017).

Pathophysiology

Normal intestinal transport and the core failure

Most gastrointestinal fluid is secreted and reabsorbed each day. The small intestine absorbs the greatest volume; the colon reclaims residual water and electrolytes. Diarrhea develops when luminal osmotic load increases, active electrolyte secretion exceeds absorption, inflammation damages the absorptive barrier, digestion or absorption fails, or transit reduces mucosal contact time. Several mechanisms may coexist in one patient (Mills & Ciorba, 2019).

Clinical Manifestations

Timing, severity, and immediate risk

Pattern	Clinical interpretation	Action priority
Acute (<7 days) or prolonged (7–13 days)	Often infectious; also medication-related or food-associated.	Volume status, exposure history, blood/fever, high-risk host.
Persistent: 14–29 days	Consider prolonged or postinfectious processes, Giardia, medications, ongoing inflammation.	Target studies to exposure, duration, and severity.
Chronic: 30 days or longer	Consider functional diarrhea, IBS-D, IBD, celiac disease, bile acid diarrhea, medication effects, and malabsorption.	Use alarm features and phenotype to direct structured testing.

Volume depletion may produce tachycardia, orthostasis, hypotension, decreased urine output, prerenal azotemia, and electrolyte or acid-base disturbances. Patients at age extremes, with reduced physiologic reserve, or with immunocompromise may deteriorate despite modest initial findings. Severe pain, peritoneal signs, shock, bloody stools, high fever, or oliguria require prompt escalation (Carbo & Smetana, 2012; Mills & Ciorba, 2019). Time-course labels distinguish acute (<7 days), prolonged (7–13 days), persistent (14–29 days), and chronic (30 days or longer) diarrhea (Shane et al., 2017).

Diagnostic Evaluation

History and diagnostic approach

• Clarify whether the complaint is loose stool, increased frequency with formed stool, fecal incontinence, or overflow around fecal impaction. Document baseline pattern, Bristol stool form, nocturnal episodes, blood, mucus, urgency, and tenesmus.
• Ask about food and water exposures, travel, sick contacts, antimicrobial use, hospitalization, dietary triggers, immune status, prior bowel or gallbladder surgery, and new prescriptions, supplements, or laxatives.
• Characterize associated pain, fever, weight loss, steatorrhea, anemia, dehydration, and extraintestinal features. Bloody diarrhea or symptoms that awaken the patient from sleep raise concern for an organic rather than purely functional disorder.
• Select testing according to presentation: electrolytes and renal function if volume loss is significant; stool pathogen testing when clinically indicated; Clostridioides difficile testing only when compatible diarrhea and risk context exist; CBC, inflammatory markers or fecal calprotectin for suspected inflammation; and celiac testing or directed malabsorption assessment for chronic patterns.
• Reserve colonoscopy with biopsies and cross-sectional imaging for appropriate indications such as alarm features, persistent unexplained inflammation, suspected inflammatory bowel disease, neoplasm, or ischemia. A normal-appearing colon does not exclude microscopic colitis.

Use phenotype to select tests rather than ordering a universal panel

Acute watery diarrhea without systemic features often needs hydration and exposure review rather than extensive stool testing. Fever, blood, severe pain, sepsis, prolonged illness, relevant travel or immunocompromise changes the case for targeted infectious studies; recent antibiotics or healthcare exposure may change the C. difficile evaluation. Chronic watery diarrhea with normal inflammatory markers can still reflect bile-acid diarrhea or microscopic colitis; microscopic colitis requires biopsies even when the mucosa appears normal (Carbo & Smetana, 2012; Mills & Ciorba, 2019).

When specialized stool-electrolyte testing is appropriate, an estimated stool osmotic gap can be calculated as 290 − 2 × (stool sodium + stool potassium), with electrolytes in mmol/L. A larger gap favors poorly absorbed osmoles; a smaller gap suggests electrolyte-rich secretory losses. Interpret the result in clinical context; stool-electrolyte testing is not routine and does not replace initial assessment of dehydration (Juckett & Trivedi, 2011).

Expected Findings

Mechanism-to-finding comparison

Mechanism	Physiologic defect	Discriminating pattern / examples
Osmotic	Nonabsorbed particles retain water within the lumen.	Often improves with fasting; carbohydrate malabsorption, magnesium-containing products, sugar alcohols.
Secretory	Chloride and water secretion increases or net electrolyte absorption decreases.	Often persists during fasting, sometimes high volume; bacterial enterotoxins, bile acid diarrhea, uncommon secretory tumors.
Inflammatory / exudative	Mucosal barrier injury reduces absorption and permits blood, protein, and inflammatory exudate into stool.	Fever, urgency, tenesmus, blood or nocturnal stools; invasive infection, inflammatory bowel disease, ischemic colitis.
Fatty / malabsorptive	Impaired intraluminal digestion, brush-border function, bile delivery or mucosal absorption leaves nutrients unabsorbed.	Bulky, greasy, hard-to-flush stools; weight loss and nutrient deficits; pancreatic insufficiency, celiac disease, ileal disease.
Altered transit / medication-associated	Reduced absorptive contact time or drug-mediated secretion and motility changes.	Review laxatives, antibiotics, metformin, magnesium, and recent medication changes; consider dumping or postsurgical states.

Differential Diagnosis

Finding	Reason to reconsider a simple functional diagnosis
Bloody diarrhea with urgency, tenesmus, elevated fecal calprotectin	Inflammatory bowel disease, infectious colitis, and ischemia remain in the differential; calprotectin does not identify etiology.
Nocturnal watery diarrhea continuing without meals	Secretory physiology; review medication-related and microscopic colitis causes.
Greasy stool, weight loss, and fat-soluble vitamin deficiency	Fat maldigestion or malabsorption; evaluate pancreas, bile delivery, and small-bowel disease.
Loose stool following partial ileal resection or cholecystectomy	Consider bile acid-related diarrhea in the appropriate setting.
Diarrhea after antibiotics with fever and abdominal pain	Assess for C. difficile and other infectious etiologies before using antimotility therapy.

Diagnostic Limitations and Reassessment

Chronic watery diarrhea with normal inflammatory markers can still reflect bile-acid diarrhea or microscopic colitis; microscopic colitis requires biopsies even when the mucosa appears normal (Carbo & Smetana, 2012; Mills & Ciorba, 2019).

Treatment and Management

Mechanism-linked treatment priorities

• Restore and maintain intravascular volume and electrolytes. Oral rehydration solutions exploit preserved sodium-glucose cotransport and are preferable to plain water alone for meaningful diarrheal losses; use IV isotonic fluids when shock, severe dehydration, or inability to tolerate oral replacement is present.
• Remove an identified offending drug or dietary substrate when feasible. Treat proven or strongly suspected infectious, inflammatory, pancreatic, or malabsorptive etiologies rather than relying solely on antimotility agents.
• Avoid routine empiric antibiotics for uncomplicated watery diarrhea. Loperamide should not be given to patients younger than 18 years with acute diarrhea. In adequately hydrated, immunocompetent adults, it may be considered for acute watery diarrhea, but avoid it when fever, bloody stools, suspected inflammatory or invasive colitis, C. difficile infection, or toxic megacolon risk is present. The need for antimicrobial treatment depends on the pathogen, host risk, disease severity, and clinical context (Shane et al., 2017).

Complications and Red Flags

Bloody diarrhea: identify Shiga toxin before making an antibiotic decision

STEC can present with severe cramping and bloody diarrhea with little or no fever. Food or outbreak exposures and pediatric or older-adult age raise concern, but none is diagnostic. When STEC is plausible, obtain an appropriate stool Shiga toxin test or nucleic-acid assay with organism testing as indicated. Avoid empiric antibiotics and antimotility agents while STEC is suspected or confirmed unless another urgent indication changes the decision; some antibiotics may increase toxin-related complications. Give careful rehydration and monitor for hemolytic uremic syndrome (new anemia/hemolysis, thrombocytopenia, and acute kidney injury), especially in children (Centers for Disease Control and Prevention, 2024; Shane et al., 2017).

Not every inflammatory stool syndrome is STEC: fever, travel, exposure, immunocompromise, sepsis or bacteremia risk can point to other pathogens for which antimicrobials may be necessary. The clinical task is to test promptly and individualize rather than treating all bloody diarrhea with empiric antibiotics or with blanket avoidance (Shane et al., 2017).

Clinical Reasoning Priorities

Clinical reasoning example: A patient has six weeks of nocturnal diarrhea, urgency, intermittent blood, and unintentional weight loss. The persistence, bleeding, and systemic features argue against IBS as the sole explanation. Assess hydration and anemia, evaluate stool pathogens as indicated, and investigate mucosal inflammation with fecal calprotectin and endoscopy with biopsies rather than empirically labeling the illness “functional.”

---

---

References

Carbo, A. R., & Smetana, G. W. (2012). Diarrhea. In M. C. Henderson, L. M. Tierney Jr., & G. W. Smetana (Eds.), The patient history: An evidence-based approach to differential diagnosis (2nd ed., Chapter 33). McGraw Hill.

Centers for Disease Control and Prevention. (2024, May 14). Information for clinicians. https://www.cdc.gov/ecoli/hcp/guidance/index.html

Juckett, G., & Trivedi, R. (2011). Evaluation of chronic diarrhea. American Family Physician, 84(10), 1119–1126. https://www.aafp.org/pubs/afp/issues/2011/1115/p1119.html

Mills, J. C., & Ciorba, M. A. (2019). Gastrointestinal disease. In G. D. Hammer & S. J. McPhee (Eds.), Pathophysiology of disease: An introduction to clinical medicine (8th ed., Chapter 13). McGraw-Hill Education.

Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., Cantey, J., & Pickering, L. K. (2017). 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clinical Infectious Diseases, 65(12), e45–e80. https://doi.org/10.1093/cid/cix669